Signal Transduction Therapy of Diabetic Vascular Complication
Journal:
Current Signal Transduction Therapy
Volume:
2
Page:
91-100
Author(s):
Sho-ichi Yamagishi, Kazuo Nakamura, Takanori Matsui, Yumiko Yoshida, Katsuhiko Takenaka, Yuko Jinnouchi and Tsutomu Imaizumi
Platelet Resistance to the Anti-Aggregating Agents in the Insulin Resistant States
Journal:
Current Diabetes Reviews
Volume:
2
Page:
409-430
Author(s):
Physiological Significance of Resistin and Resistin-Like Molecules in the Inflammatory Process and Insulin Resistance
Journal:
Current Diabetes Reviews
Volume:
2
Page:
449-454
Author(s):
MTHFR Gene Polymorphism and Diabetic Retinopathy
Journal:
Current Diabetes Reviews
Volume:
2
Page:
467-476
Author(s):
From the Design to the Clinical Application of Thromboxane Modulators
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
903-923
Author(s):
Jean-Michel Dogne, Julien Hanson, Xavier de Leval, Domenico Pratico, Cecil R. Pace-Asciak, Pierre Drion, Bernard Pirotte and Ke-He Ruan
Angiogenic and Antiangiogenic Factors in Proliferative Diabetic Retinopathy
Journal:
Current Diabetes Reviews
Volume:
2
Page:
71-98
Author(s):
Rafael Simo, Esther Carrasco, Marta Garcia-Ramirez and Cristina Hernandez
Towards Newer Molecular Targets for Chronic Diabetic Complications
Journal:
Current Vascular Pharmacology
Volume:
4
Page:
45-57
Author(s):
Zia A. Khan, Hana Farhangkhoee and Subrata Chakrabarti
Epoxyeicosatrienoic Acids as a Therapeutic Target for Nephropathy Associated with Diabetes and Hypertension
Journal:
Current Hypertension Reviews
Volume:
1
Page:
235-242
Author(s):
Jeffrey J. Olearczyk and John D. Imig
Diabetic Vascular Complications: Pathophysiology, Biochemical Basis and Potential Therapeutic Strategy
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2279-2299
Author(s):
Sho-ichi Yamagishi and T. Imaizumi
Blood Platelet Reactivity and its Pharmacological Modulation in (People with) Diabetes Mellitus
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2331-2365
Author(s):
C. Watala